- Comorbidities, complications and the site of metastasis (N=419).
| Variable | n (%) |
|---|---|
| Comorbidities (n=414) (missing=5) | |
| Hypertension | 118 (28.5) |
| Diabetes mellitus | 100 (24.2) |
| Thyroid disease | 77 (18.6) |
| Musculoskeletal disease | 41 (9.9) |
| Dyslipidemia | 30 (7.3) |
| Bronchial asthma | 26 (6.3) |
| Gynecological disease | 24 (5.8) |
| Cardiovascular disease | 22 (5.3) |
| Renal disease | 9 (2.2) |
| Hepatitis | 5 (1.2) |
| Complications (n=417) (missing=2) | |
| Progression to advanced stage | 33 (7.9) |
| DVT/PE | 8 (1.9) |
| Arm lymphedema | 5 (1.2) |
| Recurrence (local) | 4 (1.0) |
| Pathological fracture | 3 (0.7) |
| Progression to invasive cancer | 3 (0.7) |
| Obstructive jaundice | 1 (0.2) |
| Spinal cord compression | 1 (0.2) |
| Sepsis | 1 (0.2) |
| None | 358 (85.6) |
| Site of metastases (n=403) (missing-16) | |
| Lungs/pleurae (n=398) | 57 (14.3) |
| Bone (n=397) | 67 (16.9) |
| Liver (n=397) | 50 (12.6) |
| Brain (n=397) | 27 (6.8) |
| Mediastinal lymph nodes (n=396) | 3 (0.8) |
| Supraclavicular lymph nodes (n=397) | 1 (0.3) |